Infection Control Market Size, Trends and Growth Analysis By Type (Disinfection Products, Sterilization Products, & Services), by End-U.S.er (Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies) – Global Forecast Till 2030

Infection Control Market Overview

Market Research Future (MRFR) projects the infection control market to expand at an approximate rate of 3.70% between 2022 and 2030. Viruses, bacteria, fungus, and parasites are the most common causes of infection. Infections include stomach and intestinal infections, lung and respiratory infections, eye and ear infections, hospital-acquired infections (HAIs), skin infections, and sexually transmitted infections. Cross infection from the surface and skin of the patient, equipment, and healthcare personnel can cause these illnesses. In order to avoid these diseases, infection management is the most effective preventive measure.

The global infection control market is driven by the increasing number of healthcare facilities around the world. The rise in the incidence of hospital-acquired infections, the rise in the number of surgical procedures requiring high-intensity infection prevention and control, the rise in the number of government awareness programs aimed at ensuring high-level infection prevention, the rise in the geriatric population, and the rise in cases of chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders are all expected to fuel market growth.

Segmentation

The infection control market has been segmented on the basis of type and end-U.S.er.

On the basis of type, the global infection control market can be segmented into disinfection products, sterilization products and services, and others.

The disinfection product is categorized into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors.

Disinfectants are further categorized by type, by formulation, and by EPA classification.

Disinfectants, by type, are classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The disinfectant by formulation is categorized into disinfectant wipes, disinfectant liquids, and disinfectant sprays. EPA classification is categorized into low-level disinfectants, intermediate-level disinfectants, and high-level disinfectants.

Medical nonwovens are classified into surgical drapes, surgical gowns, sterilization wraps, and face masks. Disinfectors are classified into washer disinfectors, flusher disinfectors, and UV ray disinfectors. Endoscope reprocessors are classified into automated endoscope reprocessors, endoscope tracking systems, and other endoscopic reprocessing products.

Sterilization products and services are classified into sterilization equipment, contract sterilization services, by type, and consumables and accessories.

Sterilization equipment are segmented into heat sterilization equipment, low-temperature sterilization, filtration sterilization, and radiation sterilization. Heat sterilization equipment are categorized into moist heat sterilizers and dry heat sterilizers. The low-temperature sterilization is categorized into Ethylene Oxide Sterilizers (EtO), hydrogen peroxide sterilizers, ozone sterilizers, formaldehyde sterilizers, and other low-temperature sterilization.

Contract sterilization services, by type is segmented into Ethylene Oxide Sterilization (EtO) services, gamma sterilization services, e-beam sterilization services, steam sterilization services, and other contract sterilization services.

The consumables and accessories are segmented into sterilization indicators, sterilant cassettes, and other consumables and accessories.

On the basis of end-U.S.er, the global infection control market is segmented into hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others.

Figure 1: - Global Infection Control Market Share, by Region

Regional Analysis

The global infection control market consists of four regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region accounted for the largest market share of the global infection control market owing to the increasing awareness about chronic infections along with the growing number of service providers. These factors are driving the market growth in the region. Moreover, the U.S. contributes to a significant market share for the infection control industry.

The European infection control market is the second largest market followed by Asia Pacific. The Asia Pacific region is expected to exhibit the fastest growth throughout the forecast period owing to the growing healthcare expenditure, exceptional healthcare standards and infrastructure, and growing presence of outsourcing organizations across this region. For instance, a voluntary organization namely the Asia Pacific Society of Infection Control (APSIC) is working in collaborations and partnerships to facilitate the quality improvement and conducts infection control research for promoting cost-efficient practices throughout the Asia Pacific region. Moreover, the presence of various government organizations dedicated to improving the standards for infection control is among the significant factors contributing toward the growth of the Asia Pacific region.

The Middle Eastern region is expected to grow at a steady pace owing to factors such as the extensive development of the healthcare infrastructure and increasing R&D activities in the healthcare sector.

Infection Control Market Key Players

The World Health Organization (WHO) has released the first-ever worldwide report on infection prevention and control. According to the current analysis, good IPC programs can cut healthcare infections by 70%. While focusing on the suffering caused by HAIs and antimicrobial resistance to patients and healthcare workers, the report also considers the impact and cost-effectiveness of infection prevention and control programs, as well as the strategies and resources available to countries to improve them.

TELA Bio Inc., a surgical reconstruction firm, will be developing SiteGuard No-Rinse Antimicrobial Solution that can be utilized in plastic reconstructive surgery. SiteGuard employs Next Science's XBIO Technology, which helps to prevent post-operative and surgical site infections by addressing biofilms, which make bacteria more resistant to disinfectants, host immune responses, and antimicrobial drugs. The company is dedicated to offering surgeons cutting-edge, cost-effective soft-tissue procedures.

Intended Audience

• Pharmaceutical and biotechnology companies


• Contract Research Organizations (CROs)


• Contract Manufacturing Organizations (CMOs)


• Contract sterilization service providers


• Sterilization and disinfection service providers


• Clinical and Diagnostic Labs


• Regulatory bodies


• Medical device companies


• Food and beverage companies


• Healthcare providers


• Research and consulting firms


• Venture capitalists and investors